T-SPOT, another broadly applied interferon-gamma release assay used in clinics, has been found to have a relatively higher sensitivity (78.4%) and specificity (59.0 to 93.0%) for TB compared with traditional culture, although a low accuracy in EPTB has been reported [18]. The gene discussed is IFNG; the disease is tuberculosis.